Panbela Therapeutics Stock Technical Analysis
PBLADelisted Stock | USD 2.06 0.11 5.07% |
As of the 29th of November, Panbela Therapeutics holds the Variance of 132.71, coefficient of variation of (506.98), and Risk Adjusted Performance of (0.14). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Panbela Therapeutics, as well as the relationship between them.
Panbela Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Panbela, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PanbelaPanbela |
Panbela Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Panbela Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Panbela Therapeutics Trend Analysis
Use this graph to draw trend lines for Panbela Therapeutics. You can use it to identify possible trend reversals for Panbela Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Panbela Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Panbela Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Panbela Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.25 , which may suggest that Panbela Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2447.81, which is the sum of squared deviations for the predicted Panbela Therapeutics price change compared to its average price change.About Panbela Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Panbela Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Panbela Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Panbela Therapeutics price pattern first instead of the macroeconomic environment surrounding Panbela Therapeutics. By analyzing Panbela Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Panbela Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Panbela Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Panbela Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Panbela help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Panbela from various momentum indicators to cycle indicators. When you analyze Panbela charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.14) | |||
Market Risk Adjusted Performance | (8.29) | |||
Mean Deviation | 7.11 | |||
Coefficient Of Variation | (506.98) | |||
Standard Deviation | 11.52 | |||
Variance | 132.71 | |||
Information Ratio | (0.21) | |||
Jensen Alpha | (2.31) | |||
Total Risk Alpha | (4.02) | |||
Treynor Ratio | (8.30) | |||
Maximum Drawdown | 88.58 | |||
Value At Risk | (17.30) | |||
Potential Upside | 10.7 | |||
Skewness | (1.07) | |||
Kurtosis | 8.2 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |